Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP3A | 8 | 2015 | 46 | 1.910 |
Why?
|
| Microsomes, Liver | 9 | 2017 | 96 | 1.410 |
Why?
|
| Isoniazid | 4 | 2016 | 64 | 1.320 |
Why?
|
| Antitubercular Agents | 5 | 2016 | 263 | 1.260 |
Why?
|
| Aldehydes | 3 | 2015 | 28 | 1.220 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2017 | 111 | 1.100 |
Why?
|
| Ritonavir | 3 | 2011 | 45 | 1.020 |
Why?
|
| Liver | 9 | 2017 | 1742 | 0.840 |
Why?
|
| HIV Protease Inhibitors | 3 | 2017 | 45 | 0.780 |
Why?
|
| Metabolomics | 12 | 2017 | 455 | 0.750 |
Why?
|
| Chemical and Drug Induced Liver Injury | 5 | 2016 | 134 | 0.740 |
Why?
|
| Pyridines | 2 | 2010 | 251 | 0.580 |
Why?
|
| Quinazolines | 2 | 2017 | 179 | 0.550 |
Why?
|
| Acetaminophen | 4 | 2013 | 97 | 0.530 |
Why?
|
| Receptors, Melatonin | 1 | 2016 | 2 | 0.500 |
Why?
|
| Xenobiotics | 2 | 2018 | 27 | 0.490 |
Why?
|
| Acetamides | 1 | 2016 | 44 | 0.480 |
Why?
|
| Homeostasis | 5 | 2017 | 677 | 0.470 |
Why?
|
| Liver Diseases | 1 | 2019 | 381 | 0.460 |
Why?
|
| Mice | 28 | 2019 | 17680 | 0.460 |
Why?
|
| Receptors, Steroid | 2 | 2013 | 162 | 0.450 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 130 | 0.450 |
Why?
|
| Saquinavir | 1 | 2013 | 5 | 0.420 |
Why?
|
| Metabolome | 3 | 2011 | 315 | 0.390 |
Why?
|
| Rifampin | 1 | 2013 | 118 | 0.370 |
Why?
|
| Bile Acids and Salts | 6 | 2016 | 243 | 0.360 |
Why?
|
| Lopinavir | 1 | 2011 | 7 | 0.360 |
Why?
|
| Animals | 30 | 2019 | 33157 | 0.360 |
Why?
|
| Hepatocytes | 5 | 2016 | 231 | 0.350 |
Why?
|
| Hydrazones | 1 | 2011 | 17 | 0.350 |
Why?
|
| Monoterpenes | 1 | 2011 | 7 | 0.350 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 92 | 0.350 |
Why?
|
| Clozapine | 1 | 2011 | 26 | 0.340 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 576 | 0.340 |
Why?
|
| Hydrazines | 1 | 2010 | 28 | 0.340 |
Why?
|
| Cholesterol | 3 | 2019 | 536 | 0.330 |
Why?
|
| Membrane Proteins | 2 | 2015 | 1570 | 0.330 |
Why?
|
| Oligopeptides | 1 | 2010 | 115 | 0.330 |
Why?
|
| Recombinant Proteins | 5 | 2017 | 1282 | 0.330 |
Why?
|
| Pyrones | 1 | 2010 | 6 | 0.320 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 76 | 0.320 |
Why?
|
| Biotransformation | 3 | 2016 | 53 | 0.310 |
Why?
|
| Glutathione | 3 | 2017 | 195 | 0.310 |
Why?
|
| Feces | 4 | 2016 | 702 | 0.300 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 3 | 2015 | 10 | 0.280 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 373 | 0.270 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 190 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1758 | 0.250 |
Why?
|
| Mice, Knockout | 7 | 2018 | 3716 | 0.250 |
Why?
|
| Isoenzymes | 2 | 2016 | 213 | 0.230 |
Why?
|
| Protoporphyrins | 2 | 2016 | 7 | 0.230 |
Why?
|
| Carnitine | 2 | 2016 | 64 | 0.220 |
Why?
|
| Atazanavir Sulfate | 2 | 2017 | 6 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 398 | 0.220 |
Why?
|
| Dealkylation | 3 | 2014 | 4 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 321 | 0.200 |
Why?
|
| Liver Regeneration | 2 | 2013 | 38 | 0.200 |
Why?
|
| Drug Overdose | 2 | 2013 | 71 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 4510 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2C8 | 2 | 2014 | 2 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2C19 | 2 | 2014 | 25 | 0.190 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2014 | 39 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2015 | 306 | 0.180 |
Why?
|
| Humans | 26 | 2019 | 127099 | 0.170 |
Why?
|
| Hydroxylation | 2 | 2011 | 50 | 0.170 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 58 | 0.160 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 203 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 322 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 2309 | 0.150 |
Why?
|
| Mice, Inbred ICR | 2 | 2016 | 152 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 193 | 0.150 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2018 | 30 | 0.150 |
Why?
|
| Glucose | 3 | 2017 | 783 | 0.150 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 39 | 0.140 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 24 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2018 | 4484 | 0.140 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 82 | 0.140 |
Why?
|
| Naphthalimides | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 99 | 0.140 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2018 | 58 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2018 | 84 | 0.130 |
Why?
|
| Fibronectins | 1 | 2017 | 99 | 0.130 |
Why?
|
| Fluorometry | 1 | 2017 | 25 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2017 | 51 | 0.130 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 73 | 0.130 |
Why?
|
| Phospholipase D | 1 | 2016 | 7 | 0.130 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2016 | 16 | 0.130 |
Why?
|
| Vitamin B 6 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cysteamine | 1 | 2016 | 15 | 0.130 |
Why?
|
| Cystinosis | 1 | 2016 | 15 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 48 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2017 | 147 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 87 | 0.130 |
Why?
|
| Semicarbazides | 1 | 2016 | 2 | 0.120 |
Why?
|
| Male | 16 | 2019 | 62658 | 0.120 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 32 | 0.120 |
Why?
|
| Naphthalenes | 1 | 2016 | 38 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 248 | 0.120 |
Why?
|
| Bufanolides | 1 | 2015 | 13 | 0.120 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 9 | 0.120 |
Why?
|
| Imines | 1 | 2015 | 10 | 0.120 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 14 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 53 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 644 | 0.110 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2015 | 7 | 0.110 |
Why?
|
| Jaundice, Obstructive | 1 | 2015 | 5 | 0.110 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2015 | 7 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2311 | 0.110 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 291 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 132 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 256 | 0.110 |
Why?
|
| Lithocholic Acid | 1 | 2014 | 3 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2016 | 202 | 0.110 |
Why?
|
| Diarylquinolines | 1 | 2014 | 5 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 253 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 742 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 291 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2015 | 286 | 0.100 |
Why?
|
| Antidotes | 1 | 2013 | 10 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 189 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 405 | 0.100 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 91 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2013 | 79 | 0.100 |
Why?
|
| Heme | 1 | 2013 | 52 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 871 | 0.100 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 148 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 154 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2017 | 642 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 533 | 0.090 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 393 | 0.090 |
Why?
|
| Cornea | 1 | 2016 | 551 | 0.090 |
Why?
|
| Mitochondria | 2 | 2016 | 728 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 271 | 0.090 |
Why?
|
| Inflammation | 2 | 2016 | 1433 | 0.090 |
Why?
|
| Neutrophils | 1 | 2014 | 355 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 929 | 0.090 |
Why?
|
| Amino Acids, Essential | 1 | 2011 | 22 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 973 | 0.090 |
Why?
|
| Ketoconazole | 1 | 2010 | 10 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1277 | 0.090 |
Why?
|
| Sophora | 1 | 2010 | 1 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 22 | 0.080 |
Why?
|
| Kynuramine | 1 | 2010 | 1 | 0.080 |
Why?
|
| Animal Structures | 1 | 2010 | 9 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 Inhibitors | 1 | 2010 | 4 | 0.080 |
Why?
|
| Melatonin | 1 | 2010 | 28 | 0.080 |
Why?
|
| Biocatalysis | 1 | 2010 | 33 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2010 | 33 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 1140 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 362 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2010 | 236 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 799 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 276 | 0.070 |
Why?
|
| Energy Metabolism | 3 | 2017 | 749 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 90 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2010 | 280 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 562 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 322 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 3233 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 4446 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 346 | 0.060 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 300 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2586 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2896 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3502 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 349 | 0.050 |
Why?
|
| Necrosis | 2 | 2015 | 191 | 0.050 |
Why?
|
| Cell Survival | 2 | 2016 | 841 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 2397 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 350 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1589 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2856 | 0.050 |
Why?
|
| Female | 7 | 2018 | 68483 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 3 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 14 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2019 | 14 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 47 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 116 | 0.040 |
Why?
|
| Oxazines | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 61 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 42 | 0.030 |
Why?
|
| Cytochromes | 1 | 2017 | 7 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 32 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 948 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 46 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2017 | 77 | 0.030 |
Why?
|
| Pyridones | 1 | 2018 | 137 | 0.030 |
Why?
|
| Glucagon | 1 | 2017 | 94 | 0.030 |
Why?
|
| Chimera | 1 | 2017 | 79 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 2541 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 105 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 134 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 83 | 0.030 |
Why?
|
| Piperazines | 1 | 2018 | 256 | 0.030 |
Why?
|
| Alkalies | 1 | 2016 | 24 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2016 | 31 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 186 | 0.030 |
Why?
|
| Cystine | 1 | 2016 | 16 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 266 | 0.030 |
Why?
|
| Exhalation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2016 | 47 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 2016 | 84 | 0.030 |
Why?
|
| Phospholipids | 1 | 2016 | 99 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 400 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 684 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 416 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1047 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 396 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Fasting | 1 | 2016 | 268 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 25 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 948 | 0.030 |
Why?
|
| Lysosomes | 1 | 2016 | 248 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 103 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 658 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 181 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 946 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 238 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 450 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 570 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 38 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 314 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 415 | 0.030 |
Why?
|
| Bile | 1 | 2014 | 44 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 516 | 0.030 |
Why?
|
| DNA Primers | 1 | 2015 | 604 | 0.030 |
Why?
|
| Cholestyramine Resin | 1 | 2013 | 13 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 108 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 196 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 118 | 0.030 |
Why?
|
| Caspases | 1 | 2014 | 156 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 968 | 0.030 |
Why?
|
| Genes, jun | 1 | 2012 | 7 | 0.020 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2014 | 81 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 30 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1019 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 58 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 95 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 76 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 108 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 60 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 62 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 162 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 714 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 524 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 416 | 0.020 |
Why?
|
| Cholestasis | 1 | 2014 | 166 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2012 | 119 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 827 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 27801 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2598 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 302 | 0.020 |
Why?
|
| Herb-Drug Interactions | 1 | 2010 | 2 | 0.020 |
Why?
|
| Quinolizines | 1 | 2010 | 7 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2759 | 0.020 |
Why?
|
| Adult | 1 | 2011 | 30435 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 97 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1598 | 0.020 |
Why?
|
| Alkaloids | 1 | 2010 | 36 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 477 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 578 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1536 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 753 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1483 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 707 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1921 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1095 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2010 | 756 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 2564 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6142 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12567 | 0.010 |
Why?
|